Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors
Robust and accurate quantification of recombinant adeno-associated virus (rAAV) vectors’ infectivity is essential for pre-clinical and clinical development of AAV gene therapy programs. The industry standard method for rAAV titration is the 50% tissue culture infectious dose (TCID50) assay using HeL...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2025-06-01
|
| סדרה: | Molecular Therapy: Methods & Clinical Development |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2329050125000877 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
